A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess safety and efficacy of the patients with MR4 therapy in GVHD prophylaxis study who
are eligible for the administration after 100 days post transplant (up to 1 year)